Internal Medicine, Interventional Cardiology · Visalia, CA
NPI
1356487656
Since 2007
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
100 Willow Plz Ste 208
Visalia, CA, 93291
Phone (559) 625-4278
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
13,161 services
Medicare patients, 2024
1,327
Average age 77
Drug cost, 2024
$5.0M
14,871 prescriptions
Company payments, 2025
$3,287
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shashi K Sharma was code 99214 (office e&m - established), 3,526 times for 968 patients. In total Shashi K Sharma billed 13,161 services in 99 codes, and Medicare paid $3.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,526 | 968 | $88.95 | $314K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 2,508 | 613 | $6.11 | $15K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 1,224 | 599 | $384.90 | $471K |
| 93306 Echocardiography (TTE/TEE) | Office | 678 | 628 | $138.52 | $94K |
| 99232 Hospital E&M - Subsequent | Facility | 647 | 160 | $57.86 | $37K |
| 93015 Electrocardiogram | Office | 629 | 615 | $56.11 | $35K |
| 78492 Myocardial Perfusion Scan | Office | 611 | 598 | $1,141.73 | $698K |
| 99233 Hospital E&M - Subsequent | Facility | 364 | 210 | $87.21 | $32K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 292 | 287 | $133.88 | $39K |
| 93000 Electrocardiogram | Office | 291 | 234 | $10.36 | $3,014 |
| 93925 Duplex Scan - Extremity Arteries | Office | 251 | 233 | $187.78 | $47K |
| 93306 Echocardiography (TTE/TEE) | Facility | 184 | 172 | $51.09 | $9,400 |
| 75716 Angiography | Office | 171 | 122 | $124.90 | $21K |
| 75625 Angiography | Office | 161 | 119 | $93.69 | $15K |
| 93458 Percutaneous Transcatheterization | Facility | 155 | 149 | $166.10 | $26K |
By year: 2022 $3.6M for 13,796 services; 2023 $3.8M for 14,200 services; 2024 $3.0M for 13,161 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shashi K Sharma prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,346 prescriptions and refills. In total Shashi K Sharma wrote 14,871 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,346 | 3,728 | 420 | $14K |
| Clopidogrel Clopidogrel Bisulfate | 908 | 2,350 | 270 | $11K |
| Metoprolol Succinate Generic | 713 | 1,835 | 205 | $9,993 |
| Ezetimibe Generic | 624 | 1,556 | 170 | $17K |
| Repatha Sureclick Evolocumab | 623 | 827 | 88 | $456K |
| Amlodipine Besylate Generic | 581 | 1,557 | 186 | $3,982 |
| Losartan Potassium Generic | 570 | 1,511 | 177 | $5,903 |
| Carvedilol Generic | 553 | 1,403 | 161 | $4,023 |
| Entresto Sacubitril/Valsartan | 532 | 1,012 | 145 | $638K |
| Rosuvastatin Calcium Generic | 492 | 1,289 | 144 | $10K |
| Eliquis Apixaban | 424 | 812 | 109 | $481K |
| Spironolactone Generic | 366 | 829 | 117 | $2,028 |
| Farxiga Dapagliflozin Propanediol | 319 | 554 | 87 | $288K |
| Pantoprazole Sodium Generic | 297 | 705 | 87 | $3,047 |
| Furosemide Generic | 255 | 585 | 89 | $986 |
Brand drugs: - claims; generic drugs: 11,278 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shashi K Sharma $3,287 ($3,287 in general payments such as food, travel and fees) from 18 companies. The largest payer was Boston Scientific Corporation with $489.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 8 | $489 |
| Amgen Inc. AMGN | 32 | $461 |
| Medtronic, Inc. MDT | 6 | $441 |
| Abiomed JNJ | 8 | $231 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $217 |
| Pfizer Inc. PFE | 17 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $203 |
| Novo Nordisk Inc NVO | 12 | $200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $155 |
| Philips North America LLC PHG | 1 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.